Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.

Medical experts address challenges and propose solutions for inter-readability concerns in nuclear medicine, particularly focusing on strategies to overcome the scarcity of specialized readers.

For patients with extremely dense breasts, contrast-enhanced mammography offered greater than 60 percent higher sensitivity than low-energy mammography for diagnosing breast cancer, according to new research.

In a recent interview, Bridget Koontz, M.D., discussed the capability of the PET imaging agent 18F-flotufolastat for diagnosing post-prostatectomy recurrence of prostate cancer in patients with PSA values less than 1 ng/mL, based on research presented at the American Society for Radiation Oncology (ASTRO) conference.

Review the case and test your knowledge to make the correct diagnosis.

Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.

In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.

Noting a rapidly changing paradigm for the treatment of rectal cancers, the authors of a new literature review discuss current and emerging principles in MRI assessment and staging.

The inclusion of the 3D imaging technology PlatinumTomo in the Mammomat B.brilliant device reportedly enables clinicians to obtain 50-degree 3D images in less than five seconds.

Eschewing the pursuit of sweet spots with RVUs, this radiologist emphasizes consistent variety in your case mix to help ensure optimal marketability.

Catch up on the top radiology content of the past week.

Offering higher diagnostic efficacy than SPECT imaging for coronary artery disease (CAD) detection, the PET myocardial perfusion imaging agent Flyrcado™ (flurpiridaz F 18, GE HealthCare) provides unit dose availability and effectiveness in imaging patients with high BMI.

Omitting biopsy procedures in men with PSA levels > 3 ng/ml and negative MRI findings for prostate cancer (PCa) was associated with significantly lower risks of diagnosing clinically insignificant PCa in comparison to the use of systematic biopsy, according to an approximately four-year study of over 13,000 men who had prostate cancer screening.

Catch up on the most-well viewed radiology content in September 2024.

The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.